Xponance, Inc. Durect Corp Transaction History

Xponance, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	SELL	$0.38 - $0.64 $4,076 - $6,865	-10,727 Closed	0 $0
Q1 2022 Apr 20, 2022	BUY	$0.55 - $0.98 $2 - $4	5 Added 0.05%	10,727 $7,000
Q4 2021 Jan 31, 2022	BUY	$0.9 - $1.31 $113 - $165	126 Added 1.19%	10,722 $11,000
Q3 2021 Nov 05, 2021	SELL	$1.21 - $1.61 $285 - $379	-236 Reduced 2.18%	10,596 $14,000
Q2 2021 Aug 12, 2021	BUY	$1.6 - $2.02 $17,331 - $21,880	10,832 New	10,832 $18,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $230M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

Stay updated on Xponance, Inc. with notifications on news.